Skip to main content

Table 1 Clinical characteristics of the study subjects

From: Effect of plasma polyunsaturated fatty acid levels on leukocyte telomere lengths in the Singaporean Chinese population

  CAD cases CAD controls P
N = 711 N = 638  
Age (years) 66.64 ± 7.84 66.37 ± 7.82 0.531
Telomere length (T/S ratio) 1.00 ± 0.23 1.02 ± 0.24 0.100
Plasma fatty acid (% of total)
 n-3 fatty acid (%) 2.63 (2.04, 3.69) 2.83 (2.11, 4.02) 0.013
 18:3 (n-3) ALA (%) 0.28 (0.21, 0.38) 0.28 (0.22, 0.38) 0.310
 20:5 (n-3) EPA (%) 0.39 (0.31, 0.49) 0.42 (0.32, 0.53) 0.002
 22:6 (n-3) DHA (%) 1.92 (1.38, 2.79) 2.02 (1.45, 3.05) 0.020
 n-6 fatty acid (%) 45.07 ± 4.68 45.43 ± 4.81 0.165
 18:2(n-6) LA (%) 36.14 ± 4.63 36.43 ± 4.68 0.252
 18:3(n-6) GLA (%) 0.19 (0.13, 0.29) 0.19 (0.13, 0.29) 0.824
 20:3(n-6) DGLA (%) 0.88 (0.67, 1.13) 0.87 (0.69, 1.10) 0.652
 20:4(n-6) AA (%) 7.57 ± 1.68 7.67 ± 1.79 0.328
 n6:n3 ratio 17.02 (11.98, 22.10) 16.14 (10.93, 21.62) 0.053
 Gender (%male) 459 (64.56%) 401 (62.85%) 0.516
rs529143    0.759
 AA 522 (75.98%) 461 (74.47%)  
 AC 155 (22.56%) 150 (24.23%)  
 CC 10 (1.46%) 8 (1.29%)  
 MAF 0.127 0.134  
  1. Data was presented as Mean ± Standard Deviation (SD) for normally distributed variables, median (interquartile range) for non-normally distributed variables or N (%) for categorical variables
  2. ALA α-Linolenic acid; EPA Eicosapentaenoic acid; DHA Docosahexaenoic acid; LA Linoleic acid; GLA γ-Linolenic acid; DGLA Dihomo-γ-linolenic acid; AA Arachidonic acid; MAF Minor allele frequency